Corpovael Sab De Stock Last Dividend Paid
| CADUA Stock | MXN 3.50 0.09 2.64% |
Corpovael SAB de fundamentals help investors to digest information that contributes to Corpovael SAB's financial success or failures. It also enables traders to predict the movement of Corpovael Stock. The fundamental analysis module provides a way to measure Corpovael SAB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Corpovael SAB stock.
Corpovael |
Corpovael SAB de Company Last Dividend Paid Analysis
Corpovael SAB's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Corpovael SAB de has a Last Dividend Paid of 0.0. This indicator is about the same for the Household Durables average (which is currently at 0.0) sector and about the same as Consumer Discretionary (which currently averages 0.0) industry. This indicator is about the same for all Mexico stocks average (which is currently at 0.0).
Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Corpovael Fundamentals
| Return On Equity | -0.0388 | |||
| Return On Asset | -0.0045 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 3.75 B | |||
| Shares Outstanding | 319.17 M | |||
| Shares Owned By Insiders | 67.70 % | |||
| Shares Owned By Institutions | 4.47 % | |||
| Price To Book | 0.17 X | |||
| Price To Sales | 0.28 X | |||
| Revenue | 2.78 B | |||
| Gross Profit | 684.78 M | |||
| EBITDA | 125.72 M | |||
| Net Income | (103.64 M) | |||
| Total Debt | 1.97 B | |||
| Book Value Per Share | 14.87 X | |||
| Cash Flow From Operations | 283.75 M | |||
| Earnings Per Share | 0.55 X | |||
| Target Price | 4.15 | |||
| Beta | -0.2 | |||
| Market Capitalization | 931.98 M | |||
| Total Asset | 10.13 B | |||
| Annual Yield | 0.13 % | |||
| Net Asset | 10.13 B |
About Corpovael SAB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Corpovael SAB de's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Corpovael SAB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Corpovael SAB de based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Corpovael Stock
Corpovael SAB financial ratios help investors to determine whether Corpovael Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Corpovael with respect to the benefits of owning Corpovael SAB security.